Graduate School of Business
Showing 201-250 of 1,264 Results
-
Nicole Kathleen Corso
Research Manager, Golub Capital Social Impact Lab, GSB Research Hub
BioNicole (she/her) received her BA in Psychology from the University of Michigan in 2016 and a MS in Health Psychology in 2018. As a masters student, she worked in the Psychiatric Affective Neuroimaging Laboratory with Israel Liberzon, MD and in the Sleep and Chronophysiology Laboratory with J. Todd Arnedt, PhD in the Department of Psychiatry at the University of Michigan. Nicole joined the Stanford Memory Lab in the Departments of Psychology and Neurology at Stanford University led by Anthony Wagner, PhD and the Mormino Lab led by Elizabeth Mormino, PhD in June 2018 to explore the memory mechanisms behind neurodegenerative disease. Nicole joined the Day Lab led by John W. Day, MD, PhD in the Department of Neurology at Stanford University in 2022 as a Data and Imaging Research Scientist to continue exploring neurological disease with the hopes of obtaining a PhD in the future.
In the Spring of 2024, Nicole transitioned into a Research Development Manager role, combining her love and passion for science and writing by assisting the Division of Hospital Medicine's faculty in developing innovative research programs and submitting competitive funding awards. Nicole was available to faculty for 1:1 grantsmanship advice and identifying funding opportunities alongside serving as their main resource for pre- and post-award support. She had helped secure over two-hundred thousand dollars in research funding within one year.
Nicole currently serves as the Research Manager of the Golub Capital Social Impact Lab in the Graduate School of Business led by Dr. Susan Athey. -
Stephen Davis
Lecturer
BioSteve Davis currently serves as a Senior Advisor with McKinsey & Company, as an Executive Advisor at the Bill & Melinda Gates Foundation, as a Stanford Graduate School of Business Lecturer and Global Health Faculty Fellow, and as a member of the Council on Foreign Relations. Steve has deep experience, including on numerous boards and advisory groups, focused on the intersection of business, innovation, and social impact. He currently serves as co-chair of the G7 Triple I Initiative to increase impact investment in global health and as chair of the Advisory Board of the Brookings/CSIS initiative on Advancing US-China Collaboration. He recently served as most recently served as co-chair of the World Health Organization’s Digital Health Technical Advisory Group, and as a Distinguished Fellow for the World Economic Forum. Steve is the former President & CEO of PATH, a leading global health innovation organization; former Director of Social Innovation at McKinsey; former CEO of Corbis, a digital media pioneer; and as an attorney with K&L Gates. With degrees from Princeton University, University of Washington, and Columbia Law School, Steve is the author of Undercurrents: Channeling Outrage to Spark Practical Activism (Wiley 2020) and speaks and writes frequently on topics related to social innovation and digital health. He lives with his family in Seattle, Washington.
-
Oscar Daniel Mier
Masters Student in Symbolic Systems, admitted Autumn 2022
Research Assistant, Stanford Institute for Innovation in Developing Economies (SEED)BioOscar Daniel Mier, a driven neuroscience professional and Master of Science candidate in Symbolic Systems at Stanford University, exemplifies unwavering dedication to neuroscience, neuroimaging, and the welfare of veterans. With a Bachelor of Science in Neuroscience from the University of California, Riverside, and graduate training in Neuroimaging and Informatics from the University of Southern California, Oscar's academic journey has propelled him through a multifaceted career. His experience includes working as a Clinical Research Coordinator at the Etkin Lab, the United States Marine Corps, and a Site Lead Clinical Research Coordinator at the U.S. Department of Veteran Affairs Palo Alto Healthcare System.
Oscar's passion for helping others shines through his work as a Mobile Training Team S.T.E.M. Fellow with the Warrior-Scholar Project, where he tutored and mentored student veterans and active service members and coordinated academic boot camps at prestigious universities. In his most recent position as a Technical Solutions Engineer at Alto Neuroscience, Oscar managed neuroimaging data and trained clinicians on clinical study paradigms. As he continues his academic journey at Stanford, Oscar brings his extensive experience, expertise, and unwavering commitment to the forefront, poised to make a lasting impact in the field of neuroscience and the lives of veterans. -
Joseph M. DeSimone
Sanjiv Sam Gambhir Professor of Translational Medicine, Professor of Chemical Engineering and, by courtesy, of Chemistry, of Materials Science and Engineering, and of Operations, Information and Technology at the Graduate School of Business
BioJoseph M. DeSimone is the Sanjiv Sam Gambhir Professor of Translational Medicine and Chemical Engineering at Stanford University. He holds appointments in the Departments of Radiology and Chemical Engineering with courtesy appointments in the Department of Chemistry and in Stanford’s Graduate School of Business.
The DeSimone laboratory's research efforts are focused on developing innovative, interdisciplinary solutions to complex problems centered around advanced polymer 3D fabrication methods. In Chemical Engineering and Materials Science, the lab is pursuing new capabilities in digital 3D printing, as well as the synthesis of new polymers for use in advanced additive technologies. In Translational Medicine, research is focused on exploiting 3D digital fabrication tools to engineer new vaccine platforms, enhanced drug delivery approaches, and improved medical devices for numerous conditions, with a current major focus in pediatrics. Complementing these research areas, the DeSimone group has a third focus in Entrepreneurship, Digital Transformation, and Manufacturing.
Before joining Stanford in 2020, DeSimone was a professor of chemistry at the University of North Carolina at Chapel Hill and of chemical engineering at North Carolina State University. He is also Co-founder, Board Chair, and former CEO (2014 - 2019) of the additive manufacturing company, Carbon. DeSimone is responsible for numerous breakthroughs in his career in areas including green chemistry, medical devices, nanomedicine, and 3D printing. He has published over 350 scientific articles and is a named inventor on over 200 issued patents. Additionally, he has mentored 80 students through Ph.D. completion in his career, half of whom are women and members of underrepresented groups in STEM.
In 2016 DeSimone was recognized by President Barack Obama with the National Medal of Technology and Innovation, the highest U.S. honor for achievement and leadership in advancing technological progress. He has received numerous other major awards in his career, including the U.S. Presidential Green Chemistry Challenge Award (1997); the American Chemical Society Award for Creative Invention (2005); the Lemelson-MIT Prize (2008); the NIH Director’s Pioneer Award (2009); the AAAS Mentor Award (2010); the Heinz Award for Technology, the Economy and Employment (2017); the Wilhelm Exner Medal (2019); the EY Entrepreneur of the Year Award (2019 U.S. Overall National Winner); and the Harvey Prize in Science and Technology (2020). He is one of only 25 individuals elected to all three branches of the U.S. National Academies (Sciences, Medicine, Engineering). DeSimone received his B.S. in Chemistry in 1986 from Ursinus College and his Ph.D. in Chemistry in 1990 from Virginia Tech.
